CHRYSTAL CAPITAL INTRODUCES CO-INVESTORS TO SECONDARY CAPITAL
Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has acted as introducer of capital to Secondary Capital on its acquisition of secondary shares in Alto Pharmacy (“Alto”), a US leading digital pharmacy.
“Secondary share purchases in well-established, profitable and well-funded tech businesses; through founder led processes, is an area that we had been trying to gain access to for some time. Having now completed our first transaction with Secondary Capital in Alto Pharmacy we look forward to working with them with regards to their investments in other US and European based opportunities.”
“Chrystal Capital introduced us to a significant number of family offices and private individuals based in both the UK and Europe. They worked alongside us to present the investment case in Alto Pharmacy and it was clear that they have the trust of their network.”
About Alto Pharmacy (“Alto”)
Alto is America's leading digital pharmacy with free hand-delivery, easy-to-reach pharmacists, and automatic savings investigations. Founded in 2015, Alto’s better pharmacy model is centered on the critical role of pharmacists as the final link in a person’s health journey and combines expert pharmacist care with purpose-built technology to deliver a more convenient and affordable experience for those who need medication. To date, Alto has fulfilled more than three million prescriptions, expanded to twelve markets, and built a mobile app experience that makes it easier than ever to manage medications and chat with a pharmacist.
For more information about Alto Pharmacy, please visit https://alto.com/.
About Chrystal Capital Co-investments
Single Family Offices (SFOs) and Ultra High Net Worth Individuals (UHNWIs) are continually seeking access to high quality, professionally structured and well managed co-investment opportunities across a range of asset classes, without having to directly source and negotiate these opportunities. The ideal scenario enables our clients to cherry pick the investment opportunities they participate in, with limited demands on their time and resources.
Through our relationships with institutional investors, we enable SFOs and UHNWIs to gain access to attractive investment opportunities that they might otherwise not be aware of. We provide curated deal flow across a variety of sectors, asset classes and structures – all tailored to known, specified preferences.
For more information about Chrystal Capital please visit https://www.chrystalcapital.com.
About Secondary Capital (“SC”)
SC was established by veteran Private Markets Investors, active in both primary and secondary transactions since the early 2000's.
SC is aligned to a fundamental shift that companies are staying private longer and need transitional capital to provide liquidity to early investors, founders and executives. SC, as a direct secondary specialist, provides liquidity to shareholders (founders, executives, VC funds and other early investors) of late-stage and growth companies.
For more information about Secondary Capital please visit https://www.secondary-capital.com.
For further information please contact:
James Innes, Managing Partner
james.innes@chrystalcapital.com
https://www.chrystalcapital.com